SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

An integrated multiplexed electrochemical platform for the selective detection of viral protein and RNA to differentiate active HIV-1 infection from vaccine induced seropositivity
Award last edited on: 4/26/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$300,000
Award Phase
1
Solicitation Topic Code
103
Principal Investigator
David Skrodzki

Company Information

Vitruvian Bio LLC

3313 Governor Henry Ct
Ellicott City, MD 21043
   (630) 439-6201
   N/A
   N/A
Location: Single
Congr. District: 03
County: Howard

Phase I

Contract Number: 75N93022C00031
Start Date: 7/1/2022    Completed: 6/30/2023
Phase I year
2022
Phase I Amount
$300,000
Development of Diagnostics to Differentiate HIV Infection from Vaccine Induced Seropositivity: Several years of clinical trials have revealed that some HIV vaccines can elicit long-lasting (rt15 years) serological immune responses that can be confused with HIV infection in common diagnostic tests. This phenomenon is known as vaccine-induced sero-reactivity or sero-positivity (VISR/VISP). The overarching goal of this program is to support the development of new serological and nucleic acid assays that can identify HIV infection while avoiding false-positive results due to VISP, with high sensitivity and specificity.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----